In prostate cancer cells, 15-LOX-1 overexpression and 13-HODE lead to PPAR gamma phosphorylation by MAPK signaling, which reduces PPAR gamma activities and increases cell proliferation and tumor growth [60,61,62]. Here, PPARG is linked to prostate carcinoma.